NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
Section snippets
Acknowledgements
We are grateful to the late Professor Tsunao Saitoh of the University of California, San Diego, for the recombinant DNA used to produce NACP. We express our appreciation to Mr. T. Hasegawa, Mr. S. Egawa, Ms. C. Tanda, Ms. Y. Ohta, Ms. J. Takasaki, Ms. K. Machida and Ms. K. Abe. This work was supported, in part, by a research grant from the Research Committee, for CNS Degenerative Diseases, the Ministry of Health and Welfare, Japan.
References (13)
- et al.
The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
Neuron
(1995) - et al.
Identification of two distinct synucleins from human brain
FEBS Lett.
(1994) - et al.
An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination
J. Neuropathol. Exp. Neurol.
(1989) - et al.
Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease
Brain
(1995) - et al.
Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study
Acta Neuropathol.
(1988) - et al.
Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
Am. J. Pathol.
(1996)
There are more references available in the full text version of this article.
Cited by (292)
Distinct growth regimes of α-synuclein amyloid elongation
2023, Biophysical JournalThe unique neuropathological vulnerability of the human brain to aging
2023, Ageing Research ReviewsImmune responses in the Parkinson's disease brain
2022, Neurobiology of DiseaseMacromolecular crowding modulates α-synuclein amyloid fiber growth
2021, Biophysical Journal
Copyright © 1997 Elsevier Science Ireland Ltd. All rights reserved.